This writer is wondering if he's violating what Warren Buffett calls a "prime rule of investing" by hanging onto one FTSE 100 struggler. The post 1 mistake to avoid, according to Warren Buffett ...
It's guessing game time again, as we all get out our crystal balls and try to predict where the FTSE 100 will go in the year ahead. The post Can the FTSE 100 hit 10,000 in 2025? Here’s what the ...
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer ...